Prospects for clinical use of reprogrammed cells for autologous treatment of macular degeneration

Since the discovery of induced pluripotent stem cells (iPSC) in 2006, the symptoms of many human diseases have been reversed in animal models with iPSC therapy, setting the stage for future clinical development. From the animal data it is clear that iPSC are rapidly becoming the lead cell type for c...

Descripción completa

Detalles Bibliográficos
Autores principales: Alvarez Palomo, Ana Belen, McLenachan, Samuel, Chen, Fred K, Da Cruz, Lyndon, Dilley, Rodney J, Requena, Jordi, Lucas, Michaela, Lucas, Andrew, Drukker, Micha, Edel, Michael J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4432516/
https://www.ncbi.nlm.nih.gov/pubmed/25984235
http://dx.doi.org/10.1186/s13069-015-0026-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4432516/
https://www.ncbi.nlm.nih.gov/pubmed/25984235
http://dx.doi.org/10.1186/s13069-015-0026-9

Ejemplares similares